Clinical Pharmacology in China: Seven Decades of Progress in Discipline Development and Education
The Journal of Clinical Pharmacology · 2026
DOI: 10.1002/jcph.70262 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Clinical Pharmacology, 2026. Verfasst von Guo-Xiang Hao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Institute of Clinical Pharmacology, Key Laboratory of Chemical Biology (Ministry of Education), State Key Laboratory…. Hauptthemen laut MEDLINE: Education, Pharmacy, Pharmacology, Clinical. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Shandong Provincial Undergraduate Teaching Reform Project, Shandong University Research Project on Undergraduate Education and Teaching Reform, Shandong University Postgraduate Education and Teaching Reform Research Project.
Abstract (Originalsprache)
Clinical pharmacology serves as the central discipline supporting rational clinical medication, innovative drug research, and full‐lifecycle pharmaceutical supervision. Domestic clinical pharmacology research began in the 1950s, and the field entered a period of rapid development after 1979 across three phases. This study sorts domestic disciplinary milestones and analyzes three key datasets: among the 1949 registered drug clinical trial institutions nationwide, nearly 50% are located in East China; investigational new drug applications surged from 446 (2012) to 3516 (2025); and the Center for Drug Evaluation issued 631 technical guidelines. The National Natural Science Foundation set up an independent clinical pharmacology discipline classification in 2015. The multi‐tiered educational system is further elaborated: the transitional 5‐year pharmacy (clinical pharmacology direction) track, standardized 5‐year clinical pharmacy undergraduate programs, and clinical pharmacology‐oriented postgraduate research sub‐disciplines under pharmacy‐related majors. Although the field has built a complete framework covering basic research, clinical practice and regulatory evaluation, critical bottlenecks persist. Clinical pharmacology is not listed as an independent major in national undergraduate and postgraduate catalogues, resulting in uneven educational standards, insufficient industry–academia integration, and striking regional gaps in disciplinary resources between eastern and inland areas. China's transitional undergraduate training model and phased regulatory improvements provide practical references for pharmaceutical regulators and educators worldwide. Targeted optimization strategies are proposed to construct unified tiered educational systems, deepen cross‐stakeholder collaborative innovation, and balance regional disciplinary layouts. The sound and balanced development of clinical pharmacology will continuously advance standardized clinical medication, accelerate domestic new drug innovations, and strengthen national public health protection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, Institute of Clinical Pharmacology, Key Laboratory of Chemical Biology (Ministry of Education), State Key Laboratory of Discovery and Utilization of Functional Components in Traditional…
- Department of Pharmacy, The Second Qilu Hospital of Shandong University, Jinan, China.
- Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Institute of Clinical Pharmacology, School of Pharmacy, Anhui Medical University, Hefei, China.
- Center for Health Outcomes Research and Delivery Science, Children's National Hospital, Washington, DC, USA.
ORCID-Profile: Guo-Xiang Hao, Yue Zhou, Wei Wei
Förderung
- Shandong Provincial Undergraduate Teaching Reform Project
- Shandong University Research Project on Undergraduate Education and Teaching Reform
- Shandong University Postgraduate Education and Teaching Reform Research Project
- Taishan Scholar Program of Shandong Province
- Distinguished Young and Middle-aged Scholar of Shandong University
- the Taishan Youth Scholar Fund of Shandong Province
Zitieren
APA
Hao, G. X., Zhou, Y., Tang, B. H., Zhao, H. J., Wei, W., van den Anker, J., & Zhao, W. (2026). Clinical Pharmacology in China: Seven Decades of Progress in Discipline Development and Education. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.70262
Vancouver
Hao GX, Zhou Y, Tang BH, Zhao HJ, Wei W, van den Anker J, et al. Clinical Pharmacology in China: Seven Decades of Progress in Discipline Development and Education. The Journal of Clinical Pharmacology. 2026. doi:10.1002/jcph.70262
BibTeX
@article{Hao2026,
author = {Hao, Guo-Xiang and Zhou, Yue and Tang, Bo-Hao and Zhao, Hua-Jun and Wei, Wei and van den Anker, John and Zhao, Wei},
title = {Clinical Pharmacology in China: Seven Decades of Progress in Discipline Development and Education},
journal = {The Journal of Clinical Pharmacology},
year = {2026},
doi = {10.1002/jcph.70262}
}
EUVIMED